President Trump today announced his intention to nominate Stephen Hahn, M.D., to lead the Food and Drug Administration. Ned Sharpless, M.D., has been serving as acting FDA commissioner since Scott Gottlieb, M.D., resigned this spring. “The AHA welcomes the nomination of Dr. Stephen Hahn, a renowned oncologist and physician leader, to be the next commissioner of the Food and Drug Administration,” said AHA President and CEO Rick Pollack. “As the chief medical executive at The University of Texas MD Anderson Cancer Center, Dr. Hahn leads the medical practice at one of the world’s top hospitals devoted to cancer care, research, education and prevention. We believe that Dr. Hahn’s more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA. The AHA looks forward to working with Dr. Hahn to achieve our mission of advancing the health of the patients and communities we are privileged to serve each day.”

Related News Articles

Headline
President Trump yesterday nominated Sarah Arbes to be assistant secretary for legislation at the Department of Health and Human Services.
Headline
John O’Brien will soon depart his position as senior advisor for drug pricing reform.
Headline
President Trump intends to nominate Adam Boehler — senior advisor to the Health and Human Services Secretary, Centers for Medicare…
Headline
Health and Human Services Secretary Alex Azar last week announced that Paul Mango will assume the role of deputy chief of staff for policy, a new position…
Headline
Health and Human Services Secretary Alex Azar today announced he will promote Assistant Secretary for Public Affairs Judy Stecker to additionally serve as…
Headline
Food and Drug Administration Commissioner Scott Gottlieb, M.D., announced that he will step down in about a month.